Search
for
Sort by
Research 481–510 of 1000+
- Rheumatologic Manifestations of Pregnancy
- Psychotropic Treatment of Psychodermatologic Disorders
- [The value of selenotherapy in patients with mucoviscidosis].
- The Belgian Ten‐Center Open Label Trial of Topical 2% Minoxidil Solution in Early Male Pattern Alopecia
- Androgenic modulation of arterial baroreceptor dysfunction and neuroinflammation in endotoxic male rats
- A novel homozygous variant in the dsp gene underlies the first case of non-syndromic form of alopecia
- [Non-motor symptoms in myasthenia gravis: attributed to T-cell clones from thymoma].
- This Week in JAMA
- Nanogenerators in Biomedical Frontiers: Revolutionizing Self-Powered Healthcare Systems
- Skin development in the gray short‐tailed opossum (<i>Monodelphis domestica</i>)—From skin respiration to thermoregulation
- A review article on pcos and its impact on quality of life in women correlation with age, basal metabolic index and various factors
- Antiaging Effect of Tea Epigallocatechin Gallate and Its Role in Modifying Aging Epigenetics: A Systematic Review
- Minoxidil Ingestion in a Toddler
- Skin, Hair, and Nail Supplements Advertised on Instagram: A Survey of Selected Posts (Preprint)
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- Diuretics
- Hair loss and cardiovascular health
- Clinical and Haemodynamic Study of Minoxidil in Moderately Hypertensive Patients
- Adrenolytic and Vasodilator Therapy
- RNA signaling in cellular plasticity during homeostasis and regeneration
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- SAT-279 The Effect of Chronic 5-alpha Reductase Inhibition on Clinically Apparent and Silent Cardiovascular Events
- SUN-364 Panhypopituitarism Induced Ventricular Tachycardia: Hormonal Relationship All Should Keep in Mind
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- THE HEART OF IT ALL: DILATED CARDIOMYOPATHY AS THE INITIAL PRESENTATION OF ANTIPHOSPHOLIPID SYNDROME
- Pericardial Disorders Occurring during Open Label Study of 3747 Patients Treated with Systemic Minoxidil
- Amla
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- 53324 Comparing Compliance, Side Effects, and Satisfaction in Oral and Topical Minoxidil
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review